Foley Todd bought AKTS
January 12, 2026 · Form 4 insider transaction
Foley Todd bought 232,870 shares of Aktis Oncology, Inc. at $18.00 per share, a transaction worth $4.19M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
232,870
Price
$18.00
Total value
$4.19M
InsiderFoley Todd
RoleDirector, 10% owner
CompanyAktis Oncology, Inc. (AKTS)
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateJanuary 12, 2026
Filing dateJanuary 14, 2026
Shares owned after4,235,403
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
The shares were purchased as follows: 219,897 by BV 2018, 8,689 by BV 2018(B) and 4,284 by AM BV2018.; The Reporting Persons disclaim beneficial ownership of the securities except to the extent of his or its pecuniary interest therein.; The shares are held as follows: 3,950,528 by BV 2018, 206,964 by BV 2018(B) and 77,911 by AM BV2018.